-+ 0.00%
-+ 0.00%
-+ 0.00%

European Undervalued Small Caps With Insider Buying To Watch

Simply Wall St·08/03/2026 05:09:40
Listen to the news

The European market has recently shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs, driven by robust corporate earnings and a recovery in AI-related stocks. Amid this backdrop, small-cap stocks are gaining attention as potential investment opportunities due to their ability to capitalize on economic growth surprises and sector-specific trends. Identifying promising small-cap stocks often involves looking for companies with strong fundamentals that can thrive in evolving market conditions.

Top 10 Undervalued Small Caps With Insider Buying In Europe

Name PE PS Discount to Fair Value Value Rating
Eurocell 12.0x 0.3x 47.14% ★★★★★☆
Nederman Holding 18.3x 0.8x 27.06% ★★★★★☆
NoHo Partners Oyj 16.7x 0.4x 34.58% ★★★★★☆
NCC 212.9x 0.3x 14.09% ★★★★☆☆
Bilia 16.7x 0.3x 30.58% ★★★★☆☆
Bytes Technology Group 18.2x 4.2x 12.41% ★★★★☆☆
CellaVision 27.2x 4.7x 43.72% ★★★☆☆☆
Genus 30.9x 2.2x 2.80% ★★★☆☆☆
KlaraBo Sverige 7.6x 3.0x -203.05% ★★★☆☆☆
Samhällsbyggnadsbolaget i Norden NA 3.1x -112.99% ★★★☆☆☆

Click here to see the full list of 55 stocks from our Undervalued European Small Caps With Insider Buying screener.

We'll examine a selection from our screener results.

Genus (LSE:GNS)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Genus is a biotechnology company specializing in animal genetics, with operations focused on providing advanced breeding services and products through its Genus ABS and Genus PIC segments, and has a market capitalization of approximately £2.09 billion.

Operations: Genus generates revenue primarily from its Genus ABS and Genus PIC segments, with the latter contributing £365.2 million. The company's gross profit margin showed a notable trend, reaching 51.33% in late 2019 before adjusting to 40.12% by late 2025. Operating expenses are significant, with research and development costs consistently around £70 million to £78 million in recent periods.

PE: 30.9x

Genus, a European small-cap company, has been gaining attention due to insider confidence with recent share purchases in early 2026. Despite facing challenges from one-off items affecting its financial results and a forecasted earnings decline of 10.7% annually over the next three years, Genus remains intriguing for investors seeking potential value plays. The company relies entirely on external borrowing for funding, adding risk but also highlighting its strategic reliance on market conditions for growth opportunities.

LSE:GNS Share price vs Value as at Aug 2026
LSE:GNS Share price vs Value as at Aug 2026

JM (OM:JM)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: JM is a construction and development company focusing on residential properties in Norway, Sweden, and Finland, with a market capitalization of SEK 30.45 billion.

Operations: JM generates revenue primarily from its operations in Norway, Sweden, and Finland, with a significant segment adjustment of SEK 4.38 billion. The company's cost structure includes substantial costs of goods sold (COGS), impacting its gross profit margin, which has shown variation over time, reaching as high as 21.86% in early 2023 before declining to 10.98% by mid-2026. Operating expenses and non-operating expenses further influence profitability, with net income margins also experiencing fluctuations across the periods analyzed.

PE: -70.9x

JM, a European construction company, is navigating a challenging financial landscape with recent earnings showing a net loss of SEK 88 million for Q2 2026. Despite this, insider confidence is evident as an individual increased their holdings by nearly 57%, investing approximately SEK 600,000. The company's strategic moves include acquiring building rights in Limhamns Sjöstad for SEK 180 million and launching new residential projects in key Swedish locations. While JM relies on external borrowing for funding, its expansion efforts could position it favorably for future growth.

OM:JM Share price vs Value as at Aug 2026
OM:JM Share price vs Value as at Aug 2026

Stenhus Fastigheter i Norden (OM:SFAST)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Stenhus Fastigheter i Norden focuses on managing and developing a diverse portfolio of properties, including offices, public properties, grocery trade locations, and warehouses/light industry/logistics facilities, with a market capitalization of SEK 1.89 billion.

Operations: Stenhus Fastigheter i Norden generates revenue primarily from its Warehouse/Light Industry/Logistics segment, contributing significantly to its income. The company's cost of goods sold (COGS) impacts its profitability, with a gross profit margin that has shown variability over the periods, reaching as high as 78.36% recently. Operating expenses are primarily driven by general and administrative costs, which have remained a substantial part of their expenditure structure.

PE: 8.1x

Stenhus Fastigheter i Norden, a small European company, has seen significant insider confidence with Mikael Nicander purchasing 11,400 shares for SEK 142,044. Their recent earnings report shows improved financial performance; second-quarter sales rose to SEK 257 million from SEK 251 million last year. However, the company's reliance on external borrowing presents higher risk. With earnings projected to grow by 7.36% annually, Stenhus may offer potential for those seeking growth in undervalued stocks despite its financial risks.

OM:SFAST Share price vs Value as at Aug 2026
OM:SFAST Share price vs Value as at Aug 2026

Where To Now?

  • Click this link to deep-dive into the 55 companies within our Undervalued European Small Caps With Insider Buying screener.
  • Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
  • Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.